Results 141 to 150 of about 65,270 (216)
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease. [PDF]
Siddiqui MS +17 more
europepmc +1 more source
Displays bar graphs showing outcome rates stratified by clinical and hemodynamic variables. Asterisks (*) denote statistically significant differences (p ≤ 0.05). “NS” indicates non‐significant comparisons. Percentages are shown above each bar. The top panel corresponds to acute kidney injury (blue bars), and the bottom panel corresponds to acute ...
Tess Calcagno +23 more
wiley +1 more source
Application of personalized nutritional diet intervention in DHBLC patients
ZHANG Ying +3 more
doaj
Early laboratory indicators of acute metabolic decompensation during emergency presentations in pediatric maple syrup urine disease. [PDF]
Oral-Cebeci S +6 more
europepmc +1 more source
Impacts of Hemodynamic Support on Ventricular Arrhythmia Ablation
ABSTRACT Background Data on the efficacy of hemodynamic support (HS) for protecting ventricular arrhythmia (VA) ablation in high‐risk heart failure (HF) patients with an impaired left ventricular function and its impact on mortality is limited. Objectives This study aimed to assess procedural efficacy, related complications, VA‐free survival, and ...
Denise Guckel +12 more
wiley +1 more source
Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study. [PDF]
Gish RG +7 more
europepmc +1 more source
Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen +11 more
wiley +1 more source
Impact of Child Pugh B Stage for the Treatment of Advanced HCC. [PDF]
Decraecker M +3 more
europepmc +1 more source
Association of GLP-1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program. [PDF]
Hwang I, Kim Y, Lee SW.
europepmc +1 more source
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon +3 more
wiley +1 more source

